Skip to content

Complete Blood Count (CBC)

Published: August 9, 2026Updated: August 17, 2026

This test checks if a newborn has been exposed to barbiturate drugs before birth by testing the baby's first stool (meconium).

Quick summary

{"Detects prenatal exposure to barbiturate medications or abuse","Meconium testing can detect drug exposure during the last half of pregnancy","Results help doctors provide appropriate care for the newborn","A positive result does not mean the baby is currently addicted","Follow-up testing may be needed for confirmation"}

Medically reviewed by WellAlly Editorial TeamLast reviewed August 17, 2026Editorial policy

Key facts at a glance

LOINC
11022-1
Short code
Barbiturates Mec-mCnc
Synonyms
Barbiturates Mec-mCnc
Category
chemistry
Sample
serum
Container
Red-top tube (SST)
Units
N/A
Ref low
3.5
Ref high
7.2
Fasting
false
Population
adult
Sex
all
Age range
18–65 years
Specimen volume
5 mL
Stability
Room temperature: 4h, Refrigerated: 24h, Frozen: 7d
Hemolysis max
500
Lipemia max
1000
Icterus max
500
TAT
4–24 hours
Order
routine

The complete blood count, commonly called a CBC, is a routine blood test that measures the different cells circulating in your blood, including red blood cells, white blood cells, and platelets. It provides your doctor with a broad snapshot of your overall health and can help identify many conditions, from anemia and infections to certain blood disorders.

The barbiturates test in meconium is a laboratory test that detects the presence of barbiturates (a type of sedative medication) in a newborn's first stool, called meconium. Meconium is the dark, sticky substance that accumulates in the baby's intestines during pregnancy and is passed in the first few days after birth.

This test is frequently done as part of a regular checkup to screen for hidden health problems, but it may also be ordered when you have symptoms such as fatigue, weakness, fever, unusual bruising, or unexplained weight loss. It helps diagnose infections, anemia, and other blood-related conditions, and it is also used to monitor chronic diseases or how well a treatment is working.

This test is performed to find out if a pregnant person used barbiturate medications or substances during pregnancy. Barbiturates are prescription medications used for sedation, sleep, or treating seizures. Sometimes these drugs may be used improperly or without medical supervision. Knowing about prenatal exposure helps healthcare providers give the newborn the proper care and monitoring they need.

A healthcare professional will draw a small sample of blood, usually from a vein in the inside of your elbow or the back of your hand, using a thin needle. The procedure takes only a few minutes, and you may feel a brief sting or pinch when the needle is inserted. A small bandage is placed over the puncture site afterward. No special preparation is normally required, although your doctor may give you specific instructions.

The sample is collected from the baby's first stool (meconium), usually within the first 24-72 hours after birth. A small amount of meconium is collected using a swab or container and sent to the laboratory for testing. The collection is simple and does not cause any discomfort to the baby.

Your results will show whether the levels of your red blood cells, white blood cells, and platelets fall within the normal range. Values that are too high or too low can point to different conditions, such as anemia, infection, inflammation, or problems with blood clotting. Many factors can influence the numbers, so your doctor will interpret them together with your symptoms, medical history, and any other test results. Always review your results with your healthcare provider to fully understand what they mean for your health.

A negative result means no barbiturates were detected in the meconium sample. A positive result indicates that the baby was exposed to barbiturates during pregnancy. The healthcare team will use this information to decide if the baby needs special care, monitoring, or treatment. It is important to remember that this test shows past exposure during pregnancy, not current poisoning.

Reference range

NCBI: Uric Acid Male 3.5-7.2 mg/dL; Female 2.5-6.8 mg/dLN/A

Specimen: serum

No special preparation usually required. Stay well hydrated. Inform your healthcare provider of all medications and supplements you are taking.

Clinical interpretation

How abnormal results are interpreted and what conditions they suggest.

Barbiturate exposure during pregnancy can affect newborn health, potentially causing withdrawal symptoms such as irritability, sleeping problems, tremors, or feeding difficulties. Early detection allows healthcare providers to monitor the baby closely and provide appropriate treatment if needed. This test is particularly important for identifying babies who may need specialized care for neonatal abstinence syndrome (NAS).

Frequently asked questions

Does a positive result mean my baby is addicted?
No, a positive result means the baby was exposed to barbiturates during pregnancy. It shows past exposure through the placenta, not current addiction. However, some babies may experience withdrawal symptoms and may need monitoring or treatment.
Will this test be done without my permission?
Testing is usually discussed with parents, but in some cases, particularly if there are concerns about the baby's health or safety, testing may be done as part of standard newborn care. Healthcare providers follow specific protocols and laws regarding testing.
What happens if the test is positive?
If the test is positive, your healthcare team will evaluate your baby for any signs of withdrawal or related health issues. They may recommend additional monitoring, supportive care, or in some cases, medication to help manage withdrawal symptoms. The team will also provide support and resources for the family.
Can the test results be wrong?
Like all laboratory tests, there is a small chance of error. Some medications or foods might cause false positive results. If the initial result is positive, doctors may order additional testing to confirm the findings.
Is this test confidential?
Yes, test results are part of the baby's medical record and are kept confidential. Healthcare providers share information only with those directly involved in the baby's care, following privacy laws and regulations.
  1. 1
  2. 2

Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 17, 2026. · Read our editorial policy